First Line Study of Irinotecan, Capecitabine and Oxaliplatin in Metastatic Gastric or Gastroesophageal Cancer.
Clinical trial NCT01129310 · COMPLETED
Trial details
- NCT number
- NCT01129310
- Sponsor
- AHS Cancer Control Alberta
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-07-01
- Primary completion
- 2018-05-18
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.